CHARLIE SHELTON: Open Payments
NPI 1861787954 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 88 payments from 23 companies in 2025. Trend: 2023 $1,767 · 2024 $1,787 · 2025 $1,650
Food & beverage: $1,650
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $190 |
| E.R. Squibb & Sons, L.L.C. | 14 | $188 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $170 |
| MERZ NORTH AMERICA, INC. | 1 | $124 |
| Merck Sharp & Dohme LLC | 7 | $122 |
| Medtronic, Inc. | 2 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $80 |
| PFIZER INC. | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
Products named: CAMZYOS, LifeVest, Xeomin, VERQUVO, COREVALVE EVOLUT R, CARDIOMEMS, JARDIANCE, ELIQUIS.
Industry payments across LA — which companies pay providers there.
